Cargando…
Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol
Fabry disease (FD) is a rare genetic disorder caused by a deficiency in the α-galactosidase A enzyme, which results in the globotriaosylceramide accumulation in many organs, including the kidneys. Nephropathy is a major FD complication that can progress to end-stage renal disease if not treated earl...
Autores principales: | Battaglia, Yuri, Bulighin, Francesca, Zerbinati, Luigi, Vitturi, Nicola, Marchi, Giacomo, Carraro, Gianni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253838/ https://www.ncbi.nlm.nih.gov/pubmed/37297884 http://dx.doi.org/10.3390/jcm12113689 |
Ejemplares similares
-
Genetic Diagnosis in a Cohort of Adult Patients with Inherited Metabolic Diseases: A Single-Center Experience
por: Lenzini, Livia, et al.
Publicado: (2022) -
El pintor Antonio Fabrés
por: Moreno, Salvador
Publicado: (1981) -
Gastrointestinal Manifestations and Low-FODMAP Protocol in a Cohort of Fabry Disease Adult Patients
por: Gugelmo, Giorgia, et al.
Publicado: (2023) -
Psychosocial determinants of healthcare use costs in kidney transplant recipients
por: Zerbinati, Luigi, et al.
Publicado: (2023) -
The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study
por: Bertoldi, Giovanni, et al.
Publicado: (2022)